Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer

Cancer

Volumn 116, Issue 20, 2010, Pages 4825-4832

  Jones, Lee W ^a   Watson, Dorothy ^a   Herndon II, James E ^a   Eves, Neil D ^b   Haithcock, Benjamin E ^c   Loewen, Gregory ^d   Kohman, Leslie ^e  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

All cause mortality; Cardiorespiratory fitness; Exercise; Lung cancer; Prognosis

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CARDIOPULMONARY EXERCISE TEST; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; KARNOFSKY PERFORMANCE STATUS; LONG TERM CARE; LUNG DIFFUSION CAPACITY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PEAK OXYGEN UPTAKE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT PARAMETERS; RISK ASSESSMENT; SEX DIFFERENCE; CAUSE OF DEATH; EXERCISE TEST; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CAUSE OF DEATH; EXERCISE TEST; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PREOPERATIVE PERIOD;

EID: 77954983288     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25396     Document Type: Article

References (38)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96. (Pubitemid 351521864)
2. Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008;100:1672-1694.
3. Blanchon F, Grivaux M, Asselain B, et al. 4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index. Lancet Oncol. 2006;7:829-836. (Pubitemid 44464064)
4. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest. 2002;122:1037-1057.
5. Jones LW, Eves ND, Haykowsky M, Joy AA, Douglas PS. Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. Lancet Oncol. 2008;9:757-765. (Pubitemid 352038314)
6. Jones LW, Eves ND, Haykowsky M, Freedland SJ, Mackey JR. Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol. 2009;10:598-605.
7. Kavanagh T, Mertens DJ, Hamm LF, et al. Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation. Circulation. 2002;106:666-671. (Pubitemid 34851924)
8. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793-801. (Pubitemid 34987553)
9. Loewen GM, Watson D, Kohman L, et al. Preoperative exercise Vo2 measurement for lung resection candidates: results of Cancer and Leukemia Group B Protocol 9238. J Thorac Oncol. 2007;2:619-625. (Pubitemid 47171783)
10. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211-277.
11. Fitzgerald MD, Tanaka H, Tran ZV, Seals DR. Age-related declines in maximal aerobic capacity in regularly exercising vs. sedentary women: a meta-analysis. J Appl Physiol. 1997;83:160-165. (Pubitemid 27304745)
12. Wilson TM, Tanaka H. Meta-analysis of the age-associated decline in maximal aerobic capacity in men: relation to training status. Am J Physiol Heart Circ Physiol. 2000;278:H829-H834. (Pubitemid 30152539)
13. Kavanagh T, Mertens DJ, Hamm LF, et al. Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. J Am Coll Cardiol. 2003;42:2139-2143. (Pubitemid 37549899)
14. Gitt AK, Wasserman K, Kilkowski C, et al. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation. 2002;106:3079-3084. (Pubitemid 35440292)
15. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA. 2005;293:2479-2486. (Pubitemid 40705729)
16. Meyerhardt JA, Giovannucci EL, Holmes MD, et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol. 2006;24:3527-3534. (Pubitemid 46630522)
17. Myers J, Gullestad L, Vagelos R, et al. Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med. 1998;129:286-293. (Pubitemid 28394573)
18. Kasymjanova G, Correa JA, Kreisman H, et al. Prognostic value of the 6-minute walk in advanced non-small cell lung cancer. J Thorac Oncol. 2009;4:602-607.
19. Jones LW, Eves ND, Hawkowsky M, Freedland SJ, Mackey JR. Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol. 2009;10:598-605.
20. Wisloff U, Najjar SM, Ellingsen O, et al. Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science. 2005;307:418-420. (Pubitemid 40139985)
21. McTiernan A. Mechanisms linking physical activity with cancer. Nat Rev Cancer. 2008;8:205-211. (Pubitemid 351301840)
22. Jones LW, Viglianti BL, Tashjian JA, et al. Effect of aerobic exercise on tumor physiology in an animal model of human breast cancer. J Appl Physiol. 2010;108:343-348.
23. Springer J, von Haehling S, Anker SD. The need for a standardized definition for cachexia in chronic illness. Nat Clin Pract Endocrinol Metab. 2006;2:416-417. (Pubitemid 44214045)
24. Antoun S, Baracos VE, Birdsell L, Escudier B, Sawyer MB. Low body mass index and sarcopenia associated with doselimiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol. [published online ahead of print January 20, 2010.]
25. Prado CM, Baracos VE, McCargar LJ, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009;15:2920-2926.
26. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629-635.
27. von Haehling S, Horwich TB, Fonarow GC, Anker SD. Tipping the scale: heart failure, body mass index, and prognosis. Circulation. 2007;116:588-590. (Pubitemid 47356342)
28. Win T, Jackson A, Groves AM, Sharples LD, Charman SC, Laroche CM. Comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer. Thorax. 2006;61:57-60. (Pubitemid 43106979)
29. Beckles MA, Spiro SG, Colice GL, Rudd RM. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest. 2003;123(1 suppl):105S-114S. (Pubitemid 36135708)
30. Beckles MA, Spiro SG, Colice GL, Rudd RM. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest. 2003;123(1 suppl):97S-104S. (Pubitemid 36135707)
31. Dales RE, Dionne G, Leech JA, Lunau M, Schweitzer I. Preoperative prediction of pulmonary complications following thoracic surgery. Chest. 1993;104:155-159. (Pubitemid 23204549)
32. Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: the evidence. CMAJ. 2006;174:801-809.
33. Erikssen G, Liestol K, Bjornholt J, Thaulow E, Sandvik L, Erikssen J. Changes in physical fitness and changes in mortality. Lancet. 1998;352:759-762. (Pubitemid 28404556)
34. Jones LW, Eves ND, Wane E, Joy AA. Exercise therapy across the lung cancer continuum. Curr Opin Oncol. 2009;11:255-262.
35. Jones LW, Peddle CJ, Eves ND, et al. Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions. Cancer. 2007;110:590-598. (Pubitemid 47106148)
36. Jones LW, Eves ND, Peterson BL, et al. Safety and feasibility of aerobic training on cardiopulmonary function and quality of life in postsurgical nonsmall cell lung cancer patients: a pilot study. Cancer. 2008;113:3430-3439.
37. Pignon JP, Tribodet H, Scagliotti GV, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol. 2008;26:3552-3559.
38. Jones LW, Eves ND, Kraus WE, et al. The Lung Cancer Exercise Training Study: a randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: rationale and design. BMC Cancer. 2010;10:155.